• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

囊性纤维化患儿呼吸道中除铜绿假单胞菌外的非发酵革兰氏阴性杆菌的出现情况。

Occurrence of nonfermentative gram-negative rods other than Pseudomonas aeruginosa in the respiratory tract of children with cystic fibrosis.

作者信息

Baltimore R S, Radnay-Baltimore K, von Graevenitz A, Dolan T F

出版信息

Helv Paediatr Acta. 1982;37(6):547-54.

PMID:6820015
Abstract

There have been no comprehensive microbiologic studies of the frequency of respiratory colonization with nonfermentative gram-negative rods (NFGNR) other than Pseudomonas aeruginosa in patients with cystic fibrosis (CF). Records of bacteria isolated from throats and sputa of CF patients of the Yale-New Haven Hospital CF Clinic from 1975-1979 were reviewed in order to determine the incidence of these species. Thirty-one strains were recovered. Twenty patients from the CF Clinic (with an average census of 170 patients) yielded at least one isolate of non-P. aeruginosa NFGNR, and eight of them showed more than one species on at least one occasion. Two patients also carried P. aeruginosa and ten carried Staphylococcus aureus on at least one occasion. Using a standardized method of clinical scoring, our patients had a course not unlike our general CF population.

摘要

除铜绿假单胞菌外,针对囊性纤维化(CF)患者呼吸道被非发酵革兰氏阴性杆菌(NFGNR)定植的频率,尚未开展全面的微生物学研究。回顾了1975 - 1979年耶鲁-纽黑文医院CF诊所CF患者咽喉和痰液中分离出的细菌记录,以确定这些菌种的发生率。共分离出31株菌株。CF诊所的20名患者(平均普查人数为170名患者)至少分离出一株非铜绿假单胞菌NFGNR,其中8名患者至少有一次显示出不止一种菌种。两名患者还至少有一次携带铜绿假单胞菌,10名患者至少有一次携带金黄色葡萄球菌。采用标准化临床评分方法,我们的患者病程与普通CF人群并无不同。

相似文献

1
Occurrence of nonfermentative gram-negative rods other than Pseudomonas aeruginosa in the respiratory tract of children with cystic fibrosis.囊性纤维化患儿呼吸道中除铜绿假单胞菌外的非发酵革兰氏阴性杆菌的出现情况。
Helv Paediatr Acta. 1982;37(6):547-54.
2
[Isolated pathogen microorganisms in respiratory samples from children with cystic fibrosis].[囊性纤维化患儿呼吸道样本中的分离病原菌微生物]
Rev Argent Microbiol. 2005 Jul-Sep;37(3):129-34.
3
[Bacteriology of mucoviscidosis during a 5-year period].[五年间黏液黏稠症的细菌学研究]
Enferm Infecc Microbiol Clin. 1992 Jan;10(1):34-8.
4
Post-operative infections in cystic fibrosis and non-cystic fibrosis patients after lung transplantation.肺移植术后囊性纤维化和非囊性纤维化患者的术后感染
J Heart Lung Transplant. 2007 Sep;26(9):890-7. doi: 10.1016/j.healun.2007.07.002.
5
A novel chromogenic medium for isolation of Pseudomonas aeruginosa from the sputa of cystic fibrosis patients.一种用于从囊性纤维化患者痰液中分离铜绿假单胞菌的新型显色培养基。
J Cyst Fibros. 2009 Mar;8(2):143-9. doi: 10.1016/j.jcf.2008.11.003. Epub 2008 Dec 20.
6
Prevalence and antimicrobial susceptibility of microorganisms isolated from sputa of patients with cystic fibrosis.从囊性纤维化患者痰液中分离出的微生物的患病率及抗菌药敏性
J Cyst Fibros. 2008 Mar;7(2):123-7. doi: 10.1016/j.jcf.2007.06.006. Epub 2007 Aug 13.
7
[Isolation frequency of Burkholderia cepacia from cystic fibrosis patients].[从囊性纤维化患者中分离出洋葱伯克霍尔德菌的频率]
Mikrobiyol Bul. 2002 Jan;36(1):1-10.
8
Long-term, low-dose azithromycin treatment reduces the incidence but increases macrolide resistance in Staphylococcus aureus in Danish CF patients.长期、低剂量阿奇霉素治疗可降低丹麦囊性纤维化(CF)患者金黄色葡萄球菌的感染发生率,但会增加其对大环内酯类药物的耐药性。
J Cyst Fibros. 2009 Jan;8(1):58-62. doi: 10.1016/j.jcf.2008.09.001. Epub 2008 Oct 11.
9
Multiresistant Pseudomonas aeruginosa in a pediatric cystic fibrosis center: natural history and implications for segregation.一家儿科囊性纤维化中心的多重耐药铜绿假单胞菌:自然病史及其对隔离的影响
Pediatr Pulmonol. 2003 Apr;35(4):253-6. doi: 10.1002/ppul.10262.
10
Early aggressive eradication therapy for intermittent Pseudomonas aeruginosa airway colonization in cystic fibrosis patients: 15 years experience.囊性纤维化患者间歇性铜绿假单胞菌气道定植的早期积极根除治疗:15年经验
J Cyst Fibros. 2008 Nov;7(6):523-30. doi: 10.1016/j.jcf.2008.06.009. Epub 2008 Aug 9.

引用本文的文献

1
Use of the E test to assess synergy of antibiotic combinations against isolates of Burkholderia cepacia-complex from patients with cystic fibrosis.使用E试验评估抗生素联合用药对囊性纤维化患者洋葱伯克霍尔德菌复合体分离株的协同作用。
Eur J Clin Microbiol Infect Dis. 2003 Jan;22(1):28-34. doi: 10.1007/s10096-002-0852-8. Epub 2003 Jan 25.
2
Outcome of Burkholderia cepacia colonisation in an adult cystic fibrosis centre.成年囊性纤维化中心洋葱伯克霍尔德菌定植的结果
Thorax. 2002 Feb;57(2):142-5. doi: 10.1136/thorax.57.2.142.
3
Characteristics of Bordetella hinzii strains isolated from a cystic fibrosis patient over a 3-year period.
从一名囊性纤维化患者身上在3年时间内分离出的欣氏博德特氏菌菌株的特征。
J Clin Microbiol. 1996 Apr;34(4):966-9. doi: 10.1128/jcm.34.4.966-969.1996.
4
Stenotrophomonas maltophilia in cystic fibrosis patients.囊性纤维化患者中的嗜麦芽窄食单胞菌。
Eur J Clin Microbiol Infect Dis. 1995 Aug;14(8):728-9. doi: 10.1007/BF01690887.
5
In vitro activities of meropenem, PD 127391, PD 131628, ceftazidime, chloramphenicol, co-trimoxazole, and ciprofloxacin against Pseudomonas cepacia.美罗培南、PD 127391、PD 131628、头孢他啶、氯霉素、复方新诺明和环丙沙星对洋葱伯克霍尔德菌的体外活性。
Antimicrob Agents Chemother. 1993 Jan;37(1):123-5. doi: 10.1128/AAC.37.1.123.
6
Bacterial colonisation with Xanthomonas maltophilia--a retrospective study in a cystic fibrosis patient population.嗜麦芽窄食单胞菌的细菌定植——一项针对囊性纤维化患者群体的回顾性研究。
Infection. 1994 Jul-Aug;22(4):258-63. doi: 10.1007/BF01739911.
7
Isolation medium for the recovery of Pseudomonas cepacia from respiratory secretions of patients with cystic fibrosis.用于从囊性纤维化患者呼吸道分泌物中分离洋葱伯克霍尔德菌的分离培养基。
J Clin Microbiol. 1985 Jul;22(1):5-8. doi: 10.1128/jcm.22.1.5-8.1985.
8
The epidemiology of Pseudomonas cepacia in patients with cystic fibrosis.囊性纤维化患者中洋葱伯克霍尔德菌的流行病学。
Eur J Epidemiol. 1987 Dec;3(4):336-42. doi: 10.1007/BF00145642.
9
Qualitative and quantitative microbiological analysis of sputa of 102 patients with cystic fibrosis.102例囊性纤维化患者痰液的定性和定量微生物学分析。
Infection. 1987 Jul-Aug;15(4):270-7. doi: 10.1007/BF01644137.
10
Microbiology of airway disease in patients with cystic fibrosis.囊性纤维化患者气道疾病的微生物学
Clin Microbiol Rev. 1991 Jan;4(1):35-51. doi: 10.1128/CMR.4.1.35.